ChemicalBook CAS DataBase List 1009119-65-6

1009119-65-6

Name	N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid dimethyl ester hydrochloride
CAS	1009119-65-6
EINECS(EC#)	816-965-3
Molecular Formula	C40H50N8O6.2(HCl)
MDL Number	MFCD25541736
Molecular Weight	767.272
MOL File	1009119-65-6.mol

Synonyms

BMS 790052 BMS790052 HCl BMS-790052 2HCl Daclatasvir HCL Daclatasvir API Daclatasvir DiHCl DACLATASVIR(2HCl) Daclatasvir/Daklinza BMS 790052 (di HClsalt) Dacatavir dihydrochloride daclatasvir hydrochloride Daclatasvir dihydrochlorid Daclatavir Dihydrochloride Dclatasvir dihydrochloride Daclatasvir Digydrochloride Dackatasvir dihydrochloride Daclatasvir dihydrochloride BMS-790052 (dihydrochloride) Daclatasivir Dihydrochloride Daclatasvir dihydrochloride, >=98% Daclatasvir`Daclatasvir dihydrochloride Daclatasvir dihydrochloride (BMS-790052) BMS-790052; BMS790052 ; BMS 790052;DACLATASVIR Daclatasvir dihydrochloride (BMS-790052 dihydrochloride) N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)- BMS-790052;BMS790052 ;BMS 790052;DACLATASVIR;BMS-790052 DIHYDROCHLORIDE;BMS790052 DIHYDROCHLORIDE;BMS 790052 DIHYDROCHLORIDE dimethyl ((2S,2'S)-((2S,2'S)-2,2'-(5,5'-([1,1'-biphenyl]-4,4'-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl))dicarbamate N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid dimethyl ester hydrochloride N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid dimethyl ester hydrochloride USP/EP/BP Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C'-dimethyl ester, hydrochloride (1:2) Methyl (1-((2S)-2-(5-(4'-(2-(1-((methoxycarbonyl)valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate hydrochloride methyl N-[(2S)-1-[(2S)-2-[5-(4'-{2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl}-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate dihydrochloride

Chemical Properties

Melting point	>207°C (dec.)
storage temp.	-20°C Freezer
solubility	DMSO (Slightly), Methanol (Slightly), Water (Slightly)
form	Solid
color	Off-White to Yellow
InChIKey	AQVSGTIFAZLGND-DDOLUWEFNA-N
SMILES	C(N1CCC[C@H]1C1=NC=C(C2C=CC(C3C=CC(C4=CN=C([C@@H]5CCCN5C(=O)[C@H](C(C)C)NC(=O)OC)N4)=CC=3)=CC=2)N1)(=O)[C@H](C(C)C)NC(=O)OC.Cl \|&1:5,22,29,45,r\|

Hazard Information

Description

Daclatasvir dihydrochloride is a hepatitis C virus nonstructural 5A (NS5A) replication complex inhibitor which was first approved in Japan for the treatment of genotype 1 HCV patients who fail to respond to interferon plus ribavirin. The drug has also been approved for patients with untreated, chronic HCV who are eligible for interferon. Additionally, in Europe, daclatasvir was approved for use in combination with other products across genotype 1–4 HCV. Daclatasvir was discovered and developed by Bristol–Myers Squibb and a fascinating account describing the initiation of the program from a phenotypic screen and the medicinal chemistry strategy leading to the discovery of the compound has been recently reported.

Chemical Properties

Daclatasvir dihydrochloride is white to yellow powder. It is freely soluble in water (>700 mg/mL). The solubility is strongly pH-dependent and the solubility is high at low pH values.

Uses

Daclatasvir Dihydrochloride is the dihydrochloride salt form of daclatasvir, an orally available inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A) replication complex, with potential activity against HCV. Daclatasvir is used with another antiviral medication (sofosbuvir) to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. Daclatasvir should never be used without sofosbuvir. Daclatasvir and sofosbuvir may also be used with another antiviral medication (ribavirin).

Definition

ChEBI: Daclatasvir hydrochloride is a hydrochloride obtained by combining daclatasvir with two molar equivalents of hydrochloric acid. It is a potent inhibitor of nonstructural protein 5A and is used for treatment of hepatitis C. It has a role as an antiviral drug and a nonstructural protein 5A inhibitor. It contains a daclatasvir(2+).

Synthesis

Bromination of commercial 4,40-diacetylbiphenyl (58) gave 4,40-bis(bromoacetyl)biphenyl 59 in 82% yield. Alkylation of NBoc- L-proline (60) with 59 gave diester 61 which was treated with ammonium acetate to effect cyclization of the bis-ketoester to provide bis-imidazole 62 in 63% yield for the two steps. Acidic removal of the Boc protecting groups followed by recrystallization provided bis-pyrrolidine 63 in high yield. Acylation of 63 with N-(methoxycarbonyl)- L-valine (64) using N-(3-dimethylaminopropyl)-N0-ethylcarbodiimide (EDC) and 1-hydroxybenxotriazole hydrate (HOBT) provided declatasvir. The dihydrochloride salt was prepared and treated with Cuno Zet Carbon ® followed by crystallization from acetone to give daclatasvir dihydrochloride (IX) in 74% yield. Synthesis_1009119-65-6

storage

Store at -20°C

Mode of action

Daclatasvir is an inhibitor of nonstructural protein 5A (NS5A), a multifunctional protein that is an essential component of the HCV replication complex. Daclatasvir binds to the N-terminus of NS5A and inhibits both viral RNA replication and virion assembly.

Spectrum Detail

Supplier

Fuxin Long Rui Pharmaceutical

Telephone1381-0598707 13683261597

Websitehttp://www.lrpharmaceutical.com/

Shanghai Boyle Chemical Co., Ltd.

Telephone

Websitehttp://www.boylechem.com

Chembest Research Laboratories Limited

Telephone021-20908456

Websitehttp://www.BioChemBest.com

Adamas Reagent, Ltd.

Telephone4006009262 13023226327

Websitehttp://www.tansoole.com

Anhui Lianchuang Biological Medicine Co.,Ltd

Telephone0551-68779238 18056025720

Websitehttp://www.lcywhx.com/

Synches Co., Ltd.

Telephone021-53292253

Websitehttp://www.synches.com

Dalian Meilun Biotech Co., Ltd.

Telephone0411-62910999 13889544652

Websitehttp://www.meilunbio.com/

Changzhou Joyous Chemical Co., Ltd.

Telephone0519-85607258

Websitehttps://www.chemicalbook.com/ShowSupplierProductsList13820/0_EN.htm

Shanghai T&W Pharmaceutical Co., Ltd.

Telephone+86 21 61551611

Websitehttp://www.trustwe.com

Acesys Pharmatech

Telephone 18860950986

Websitehttps://www.chemicalbook.com/ShowSupplierProductsList15849/0_EN.htm

Guangzhou Isun Pharmaceutical Co., Ltd

Telephone020-39119399 18927568969

Websitehttp://www.isunpharm.com

Nanjing Sunlida Biological Technology Co., Ltd.

Telephone025-57798810 18652991625

Website

TargetMol Chemicals Inc.

Telephone021-021-33632979 15002134094

Websitehttps://www.targetmol.cn/

Suli Pharmaceutical Technology Co., Ltd.

Telephone021-58086325-8060 13636568474

Websitehttp://www.sulipharm.com/

Suzhou lipin Chemical Co., Ltd

Telephone0512-0512-67509664 19888480046

Websitehttp://www.lipinchem.com/

Quality Control Solutions Ltd.

Telephone0755-66853366 13670046396

Websitehttp://www.qcsrm.com

Shanghai YuLue Chemical Co., Ltd.

Telephone021-60345187 13671753212

Websitehttps://www.chemicalbook.com/ShowSupplierProductsList16365/0_EN.htm

Jinan Rouse Industry Co., Ltd.

Telephone0531-0531-82929600 18615510361

Websitehttp://www.rousechem.com

1of4

Related Products

Send Inquriy